Identification of B6SJL mSOD1(G93A) mouse subgroups with different disease progression rates

Disease progression rates among patients with amyotrophic lateral sclerosis (ALS) vary greatly. While the majority of affected individuals survive three – five years following diagnosis, subgroups undergo a more rapidly progressing form, surviving less than one year, or slower progressing forms surv...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Comp Neurol
Egile Nagusiak: Haulcomb, Melissa M., Mesnard-Hoaglin, Nichole A., Batka, Richard J., Meadows, Rena M., Miller, Whitney M., McMillan, Kathryn P., Brown, Todd J., Sanders, Virginia M., Jones, Kathryn J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4607568/
https://ncbi.nlm.nih.gov/pubmed/26010802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cne.23814
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak